Evidence map›Paper›PMID 25224257›Full record

ArticleMolecular psychiatry2015

DISC1 regulates trafficking and processing of APP and Aβ generation.

N Shahani, S Seshadri, H Jaaro-Peled, K Ishizuka, Y Hirota-Tsuyada, Q Wang, M Koga, T W Sedlak, C Korth, N J Brandon and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Induction ofFrontiers in aging neuroscience · 2022
    Article
  8. What Can We Learn from Animal Models to Study Schizophrenia?Advances in experimental medicine and biology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

N ShahaniDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S SeshadriDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
H Jaaro-PeledDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
K IshizukaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Y Hirota-TsuyadaDepartment of Neurosciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Q WangNeuroscience Research Unit, Pfizer, Groton, CT, USA.
M KogaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
T W SedlakDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
C KorthDepartment of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
N J BrandonNeuroscience Research Unit, Pfizer, Groton, CT, USA.
A KamiyaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S SubramaniamDepartment of Neuroscience, The Scripps Research Institute, Jupiter, FL, USA.
T TomodaDepartment of Neurosciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
A SawaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USPfizer (United States) · USBeckman Research InstituteCity of Hope · USHeinrich Heine University Düsseldorf · DEScripps Research Institute · US

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
WOUND MIGRATION FORCE MONITORINGP41RR001192 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYUBOVITSKY, JULIA · 1985 to 2011
$14.2M
Research Center for Molecular Pathogenesis of SchizophreniaP20MH084018 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2008 to 2010
$3.3M
Nuclear pathway of DISC1 in major mental illnesses: biochemistry and cell biologyR01MH069853 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2004 to 2012
$3.2M
Oxidative stress and schizophrenia: combination of cell biology and brain imagingR01MH092443 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2015
$1.8M
DISC1 Pathway in Dendritogenesis: Implications for Dopamine Circuit and CognitionR01MH091230 · NIMH · JOHNS HOPKINS UNIVERSITY · PI KAMIYA, ATSUSHI · 2010 to 2014
$1.6M
Defining of Neurodevelopmental Pathways Regulated by Neuregulin- DISC1 InteractioRC1MH088753 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANTON, EVA S, SAWA, AKIRA · 2009 to 2010
$933k
Cell signaling and cytoprotective roles of biliverdin reductaseK08NS057824 · NINDS · JOHNS HOPKINS UNIVERSITY · PI SEDLAK, THOMAS WILLIAM · 2008 to 2011
$708k
PICK1 knockout mice: role for D-serine in neonatal forebrainsR21MH085226 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2010 to 2011
$369k
NCRR NIH HHS P41 RR001192NIMH NIH HHS MH-069853NIMH NIH HHS MH-084018NIMH NIH HHS MH-085226NIMH NIH HHS MH-088753NIMH NIH HHS MH-091230NIMH NIH HHS MH-092443NIMH NIH HHS MH-094268NIMH NIH HHS P20 MH084018NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH069853NIMH NIH HHS R01 MH091230NIMH NIH HHS R01 MH092443NIMH NIH HHS R21 MH085226NIMH NIH HHS RC1 MH088753NINDS NIH HHS K08 NS057824
6 · The paper itself

Abstract

We report the novel regulation of proteolytic processing of amyloid precursor protein (APP) by DISC1, a major risk factor for psychiatric illnesses, such as depression and schizophrenia. RNAi knockdown of DISC1 in mature primary cortical neurons led to a significant increase in the levels of intracellular α-C-terminal fragment of APP (APP-CTFα) and the corresponding N-terminal-secreted ectodomain product sAPPα. DISC1 knockdown also elicited a significant decrease in the levels of amyloid beta (Aβ)42 and Aβ40. These aberrant proteolytic events were successfully rescued by co-expression of wild-type DISC1, but not by mutant DISC1 lacking the amino acids required for the interaction with APP, suggesting that APP-DISC1 protein interactions are crucial for the regulation of the C-terminal proteolysis. In a genetically engineered model in which a major full-length DISC1 isoform is depleted, consistent changes in APP processing were seen: an increase in APP-CTFα and decrease in Aβ42 and Aβ40 levels. Finally, we found that knockdown of DISC1 increased the expression of APP at the cell surface and decreased its internalization. The presented DISC1 mechanism of APP proteolytic processing and Aβ peptide generation, which is central to Alzheimer's disease pathology, suggests a novel interface between neurological and psychiatric conditions.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainCell MembraneCells, CulturedDisease Models, AnimalGene Knockdown TechniquesHumansMice, Inbred C57BLMice, KnockoutMice, TransgenicNerve Tissue ProteinsNeuronsProtein TransportRats, Sprague-DawleyAmyloid beta-PeptidesDisc1 protein, mouseDisc1 protein, ratNerve Tissue Proteins

Identifiers

PMID25224257
PMCPMC4362789
OpenAlexW1988003904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.